Capsaicin has been reported to exhibit an inhibitory effect on the P-glycoprotein (P-gp) function in vitro. To investigate its concentration-dependent effect in vivo, a sensitive assay that can characterize the absorption and disposition of capsaicin needs to be developed. This study reports the development of a sensitive LC-MS/MS assay for the determination of capsaicin in mouse plasma. The sample pretreatment involved a one-step extraction of 20 μL plasma with t-butyl methyl ether. Separations were achieved on a C18 column and the detection was performed on an LC-ESI-MS/MS by multiple reaction monitoring. The assay was linear over a wide concentration range from 0.325 to 650 ng mL−1 (r > 0.999), with a LLOQ of 0.325 ng mL−1. The developed method was applied to i.v. (dose 0.325 and 0.65 mg kg) and oral absorption (dose 40 mg kg) studies in mice. After i.v. injection, the t1/2,λz, Vz and CLs ranged from 0.13–0.16 h, 127.6–141.8 mL, and 547.3–775.4 mL/h, respectively. After oral administration, a secondary peak was observed and the terminal half-life was prolonged (1.51 h). Capsaicin was poorly absorbed, with the absolute oral bioavailability (F) ranging from 1.02% to 1.56%. The developed assay may be useful in studies where sample volumes are limited.
[1]. G.A. Cordell O.E. Araujo 1993 Ann. Pharmacother. 27 330.
[2]. M.J. Caterina M.A. Schumacher M. Tominaga T.A. Rosen J.D. Levine D. Julius 1997 Nature 389 816.
[3]. I. Tolan D. Ragoobirsingh E.Y.S.A. Morrison 2001 Phytother. Res. 15 391.
[4]. C.C. Chou Y.C. Wu Y.F. Wang M.J. Chou S.J. Kuo D.R. Chen 2009 Oncol. Rep. 21 665.
[5]. S.P. Huang J.C. Chen C.C. Wu C.T. Chen N.Y. Tang Y.T. Ho C. Lo J.P. Lin J.G. Chung J.G. Lin 2009 Anticancer Res. 29 165.
[6]. M.Y. Kim L.J. Trudel G.N. Wogan 2009 Anticancer Res. 29 3733.
[7]. K.C. Brown T.R. Witte W.E. Hardman H. Luo Y.C. Chen A.B. Carpenter J.K. Lau P. Dasgupta 2010 PLos ONE 5 1.
[8]. T. Nabekura S. Kamiyama S. Kitagawa 2005 Biochem. Biophys. Res Commun. 327 866.
[9]. O.M.E.A. Salam O.A. Heikal S. El-Shenawy 2005 Pharmacology 73 121.
[10]. D. Suresh K. Srivasan 2010 Indian J. Med. Res. 131 682.
[11]. J. Lu M. Cwik 1997 J. Chromatogr. B 701 135.
[12]. R. Wolf C. Huschka K. Raith W. Wohlrab R.H.H. Neubert 1999 J. Liquid Chromatogr. Rel. Technol. 22 531.
[13]. C.A. Reilly D.J. Crouch G.S. Yost A.A. Fatah 2002 J. Anal. Toxicol. 26 313.
[14]. S. Babbar J.F. Marier M.S. Moukassi M. Beliveau G.F. Vanhove S. Chanda K. Bley 2009 Ther. Drug Monit. 31 502.
[15]. Q. Zhang J. Hu L. Sheng Y. Li 2010 J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878 2292.
[16]. S. Chanda M. Bashir S. Babbar A. Koganti K. Bley 2008 Drug Metab. Dispos. 36 670.
[17]. B.S. Shin S.W. Hwang J.B. Bulitta J.B. Lee S.D. Yang J.S. Park M.C. Kwon D.J. Kim H.S. Yoon S.D. Yoo 2010 J. Toxicol. Environ. Health-Part A 73 1586.